China Builds Hospital Dedicated To Heavy Ion Cancer Treatment
This article was originally published in PharmAsia News
Executive SummaryChina is building a hospital in a Northwestern province it hopes to be a world magnet for heavy ion therapy for cancer patients. The head of the modern physics section of the Chinese Academy of Sciences said the Lanzhou Heavy Ion Cancer Treatment Center would be able to treat 2,000 cancer patients per year. The academy conducted clinical trials of heavy-ion treatment and reported success in eliminating most detectable tumors. It also said that in 90 percent of patients, there were no relapses after 18 months. The center is expected to cost $146 million. (Click here for more
You may also be interested in...
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced January 2020.
Industry experts expect a continued uptick in deals valued between $2bn-$10bn this year as buyers look to add critical mass in areas like oncology, rare disease and cell and gene therapy. Divestitures to free up capital and narrow focus should continue too.
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.